Background & Aims: Sildenafil shows an intense and prolonged inhibitory eff
ect on the smooth muscle cells of the human corpus cavernosum by blocking p
hosphodiesterase type 5 that destroys nitric oxide-stimulated cyclic guanos
ine monophosphate. We investigated if sildenafil possesses a similar effect
on the esophageal musculature of patients with achalasia, where there is a
n impairment of nitric oxide production similar to that of functional impot
ence. Methods: In 14 patients affected by achalasia with an esophageal diam
eter of 5 cm, esophageal motility was recorded with a low-compliance manome
tric system. After a basal period of 30 minutes, a 50-mg tablet of sildenaf
il dissolved in water was infused in the stomach in 7 patients and one of p
lacebo in the other 7 patients, randomly and in double-blind manner, contin
uing the recording for 60 minutes. Results: Lower esophageal sphincter tone
, residual pressure, and wave amplitude after sildenafil showed a significa
nt decrease compared with both the basal period and the placebo group, with
a marked interpatient variability. The inhibitory effect reached its maxim
um (about -50%) 15-20 minutes after the infusion and lasted <1 hour. Propag
ation of pressure waves was not modified by sildenafil. Conclusions: Silden
afil inhibits the contractile activity of the esophageal musculature of pat
ients with achalasia, decreasing lower esophageal sphincter tone and residu
al pressure as well as contraction amplitude.